Beyond its anti-tumor activity, increasing evidence in animal studies suggests that TRAIL plays a role in the control of autoimmune diseases, and in particular in type 1 diabetes mellitus (T1DM) [1, 2]. The gene discussed is TNFSF10; the disease is type 1 diabetes mellitus.